Aron R. English - Nov 13, 2023 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role: Director, 10%+ Owner
Signature: /s/ Aron R. English
Stock symbol: ANEB
Transactions as of: Nov 13, 2023
Transactions value $: $0
Form type: 4
Date filed: 12/20/2023, 04:22 PM
Previous filing: Oct 23, 2023
Next filing: Dec 1, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANEB	Common Stock	Award	$0	+300K		$0.00	300K	Nov 13, 2023	22NW, LP	F1, F2, F3
transaction	ANEB	Common Stock	Gift	$0	-300K	-100%	$0.00^*	0	Dec 18, 2023	22NW, LP	F3
transaction	ANEB	Common Stock	Gift	$0	+300K	+5.92%	$0.00	5.37M	Dec 18, 2023	22NW Fund, LP	F4
holding	ANEB	Common Stock						4.65M	Nov 13, 2023	Pharma Investors, LLC	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were issued to 22NW, LP as partial consideration for entering into a loan and security agreement with the Issuer.
F2	This Form 4 is filed jointly by Aron R. English, 22NW, LP and 22NW Fund, LP (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
F3	Securities owned directly by 22NW, LP. Mr. English, as the Manager of 22NW, LP may be deemed to beneficially own the securities owned directly by 22NW, LP.
F4	Securities owned directly by 22NW Fund, LP. Mr. English, as the Manager of 22NW Fund GP, LLC, which is the General Partner of 22NW Fund, LP, may be deemed to beneficially own the securities owned directly by 22NW Fund, LP.
F5	Securities owned directly by Pharma Investors, LLC. Mr. English, as the owner of Pharma Investors, LLC, may be deemed to beneficially own the securities owned directly by Pharma Investors, LLC.